Elafibranor

Records for this ingredient, by country (identity only).

ATC A05AX06 · 8 markets · 10 records

Elafibranor 8 markets · 10 records Forms
Filters

AU 3 records · 1 shown of 1 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 80 mgtabletIQIRVOIQIRVO elafibranor 80 mg film-coated tablets bottle also in US·GB·CA
    +3Other 3 marketsSGESFR
    unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 80 mgtabletIQIRVO 80 mg, comprimé pelliculé also in AU·US·GB
    +3Other 3 marketsCASGES

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.